To examine the median overall survival in patients with gross total resection versus subtotal resection of single-brain metastases, highlighting the clinical significance of this comparison.
Key Findings:
Median overall survival is generally short, around 5 months after diagnosis.
Gross total resection is preferred but can lead to increased postoperative neurological damage, necessitating careful patient selection.
Extent of resection may not significantly influence overall survival in single brain metastases with adjuvant treatment.
Interpretation:
The findings suggest that while gross total resection may improve local control, its impact on overall survival remains uncertain, warranting further investigation to validate these results.
Limitations:
Study limited to a single center, which may affect generalizability and diversity of the patient population.
Potential for selection bias in patient inclusion criteria.
Conclusion:
Further research is needed to clarify the clinical importance of the extent of resection in brain metastases, explicitly balancing survival benefits against the risk of neurological complications.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
